Puria Nabilou
Hvidovre, 2650, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Investigation of non-invasive tests for fibrosis diagnosis and prognostication of events in metabolic dysfunction-associated steatotic liver disease: A prospective study cohort.
Journal: Annals of hepatology
Published: February 27, 2026
Magnetic resonance imaging-derived extracellular volume fraction mapping in metabolic dysfunction-associated steatotic liver disease reveals subclinical cardiac remodelling.
Journal: Scientific reports
Published: January 08, 2026
Impact of non-selective beta-blockers on acute kidney injury outcomes in patients with decompensated cirrhosis.
Journal: Journal of hepatology
Published: October 25, 2025
Cardiovascular implications of MASLD: overview of the evidence.
Journal: Scandinavian journal of gastroenterology
Published: July 28, 2025
Real-World Use of Terlipressin in Cirrhosis and Acute Kidney Injury: Frequent Use Beyond Hepatorenal Syndrome.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: May 10, 2025
Diagnostics of Autoimmune Hepatitis Enabled by Non-Invasive Clinical Proteomics.
Journal: Alimentary pharmacology & therapeutics
Published: March 07, 2025
Alterations in one-carbon metabolism in metabolic dysfunction associated steatotic liver disease may be modified by semaglutide.
Journal: Annals of hepatology
Published: January 02, 2025
Mapping the hemodynamic effects of terlipressin in patients with hepatorenal syndrome using advanced magnetic resonance imaging.
Journal: JHEP reports : innovation in hepatology
Published: October 31, 2024
Global epidemiology of acute kidney injury in hospitalised patients with decompensated cirrhosis: the International Club of Ascites GLOBAL AKI prospective, multicentre, cohort study.
Journal: The lancet. Gastroenterology & hepatology
Published: September 16, 2024
Patients with autoimmune liver disease have glucose disturbances that mechanistically differ from steatotic liver disease.
Journal: American journal of physiology. Gastrointestinal and liver physiology
Published: April 16, 2024
Use of PNPLA3, TM6SF2, and HSD17B13 for detection of fibrosis in MASLD in the general population.
Journal: Clinics and research in hepatology and gastroenterology
Published: February 21, 2024
Targeted metabolomics reveals plasma short-chain fatty acids are associated with metabolic dysfunction-associated steatotic liver disease.
Journal: BMC gastroenterology
Published: November 08, 2023
Last Updated: 09/26/2026